HK1218861A1 - 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法 - Google Patents
包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法Info
- Publication number
- HK1218861A1 HK1218861A1 HK16106876.8A HK16106876A HK1218861A1 HK 1218861 A1 HK1218861 A1 HK 1218861A1 HK 16106876 A HK16106876 A HK 16106876A HK 1218861 A1 HK1218861 A1 HK 1218861A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- granules
- rifapentine
- isoniazid
- preparation
- pharmaceutical composition
- Prior art date
Links
- 239000008187 granular material Substances 0.000 title 2
- 230000002365 anti-tubercular Effects 0.000 title 1
- 239000007919 dispersible tablet Substances 0.000 title 1
- 229960003350 isoniazid Drugs 0.000 title 1
- QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- WDZCUPBHRAEYDL-GZAUEHORSA-N rifapentine Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C(O)=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N(CC1)CCN1C1CCCC1 WDZCUPBHRAEYDL-GZAUEHORSA-N 0.000 title 1
- 229960002599 rifapentine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
- A61K31/06—Phenols the aromatic ring being substituted by nitro groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4409—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 4, e.g. isoniazid, iproniazid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3342CH2013 | 2013-07-26 | ||
| PCT/EP2014/065762 WO2015011162A1 (en) | 2013-07-26 | 2014-07-22 | Anti-tuberculosis stable pharmaceutical composition in a form of a dispersible tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1218861A1 true HK1218861A1 (zh) | 2017-03-17 |
Family
ID=51211798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK16106876.8A HK1218861A1 (zh) | 2013-07-26 | 2016-06-15 | 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US9814680B2 (zh) |
| EP (1) | EP3024444A1 (zh) |
| JP (2) | JP2016539110A (zh) |
| CN (1) | CN105407876B (zh) |
| AU (1) | AU2014295099B2 (zh) |
| CA (1) | CA2918528A1 (zh) |
| CL (1) | CL2016000183A1 (zh) |
| HK (1) | HK1218861A1 (zh) |
| IL (1) | IL243369A0 (zh) |
| MX (1) | MX2016001155A (zh) |
| PE (1) | PE20160245A1 (zh) |
| PH (1) | PH12016500119A1 (zh) |
| RU (1) | RU2694056C2 (zh) |
| SA (1) | SA516370446B1 (zh) |
| SG (2) | SG11201510732VA (zh) |
| TW (1) | TWI630911B (zh) |
| WO (1) | WO2015011162A1 (zh) |
| ZA (1) | ZA201600110B (zh) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2016001156A (es) | 2013-07-26 | 2016-04-29 | Sanofi Sa | Composicion antituberculosa que comprende rifampicina, isoniazid, etambutol y pirazinamida y su proceso de preparacion. |
| WO2022098682A1 (en) * | 2020-11-09 | 2022-05-12 | Realta Life Sciences, Inc. | Peptide formulations and methods of use |
| CN112730657A (zh) * | 2020-12-18 | 2021-04-30 | 卓和药业集团有限公司 | 利福喷丁含量的分析检测方法 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1217912A (zh) | 1997-11-26 | 1999-06-02 | 岑冠新 | 复方利福喷丁制剂及制备方法 |
| MXPA02003596A (es) * | 2000-08-09 | 2003-10-14 | Panacea Biotec Ltd | Composiciones farmaceuticas novedosas de farmacos anti tubercular y procedimiento para su preparacion. |
| JP4446463B2 (ja) * | 2000-10-16 | 2010-04-07 | 第一三共株式会社 | 口腔内速崩壊性医薬組成物およびその製造方法 |
| BR0116994A (pt) | 2001-04-27 | 2004-03-02 | Lupin Ltd | Um processo aperfeiçoado para a preparação de uma composição que abrange uma combinação de dose fixa (fdc) de quatro drogas antituberculose |
| US20050059719A1 (en) | 2003-09-16 | 2005-03-17 | Badawy Sherif Ibrahim Farag | Solid dosage formulation containing a Factor Xa inhibitor and method |
| TW201233389A (en) | 2005-10-05 | 2012-08-16 | Otsuka Pharma Co Ltd | Antituberculous therapeutic drugs and kit containing the same |
| JP5105818B2 (ja) * | 2005-10-05 | 2012-12-26 | 大塚製薬株式会社 | 医薬組成物 |
| JPWO2007043452A1 (ja) * | 2005-10-12 | 2009-04-16 | パイオニア株式会社 | 車載撮影装置及び車載カメラの撮影可動範囲測定方法 |
| CN1989966B (zh) | 2005-12-30 | 2011-06-08 | 重庆华邦制药股份有限公司 | 含利福平和异烟肼的药物组合物 |
| CN1857280A (zh) * | 2006-04-11 | 2006-11-08 | 济南帅华医药科技有限公司 | 一种复方抗结核药物缓释制剂 |
| JP2010535774A (ja) * | 2007-08-06 | 2010-11-25 | インシス セラピューティクス インコーポレイテッド | 経口カンナビノイド液体製剤および治療方法 |
| KR101197277B1 (ko) * | 2009-02-05 | 2012-11-05 | (주) 벡스코아 | 경구용 결핵의 치료용 또는 예방용 고형 제형 |
| RU2012105674A (ru) | 2009-07-31 | 2013-09-10 | Кадила Фармасьютикалз Лтд. | Фармацевтическая композиция изониазида |
| US20130129791A1 (en) * | 2010-05-04 | 2013-05-23 | Mahmut Bilgic | Preparations of effervescent formulations comprising second and third generation cephalosporin and uses thereof |
| WO2012013756A2 (fr) | 2010-07-28 | 2012-02-02 | Laboratoires Pharma 5 | Procédé de préparation de comprimés contenant en association la rifampicine, l'isoniazide, la pyrazinamide, et éventuellement l'ethambutol |
| US8470365B2 (en) * | 2010-07-29 | 2013-06-25 | Taiwan Biotech Co., Ltd. | Process for preparation of anti-tubercular combination and pharmaceutical composition prepared therefrom |
| SG11201510730UA (en) | 2013-07-26 | 2016-01-28 | Sanofi Sa | Anti-tuberculosis stable pharmaceutical composition in a form of a coated tablet comprising granules of isoniazid and granules of rifapentine and its process of preparation |
| MX2016001156A (es) | 2013-07-26 | 2016-04-29 | Sanofi Sa | Composicion antituberculosa que comprende rifampicina, isoniazid, etambutol y pirazinamida y su proceso de preparacion. |
-
2014
- 2014-07-22 CN CN201480041954.5A patent/CN105407876B/zh not_active Withdrawn - After Issue
- 2014-07-22 PE PE2016000090A patent/PE20160245A1/es unknown
- 2014-07-22 JP JP2016528510A patent/JP2016539110A/ja not_active Ceased
- 2014-07-22 AU AU2014295099A patent/AU2014295099B2/en not_active Revoked
- 2014-07-22 WO PCT/EP2014/065762 patent/WO2015011162A1/en active Application Filing
- 2014-07-22 MX MX2016001155A patent/MX2016001155A/es unknown
- 2014-07-22 RU RU2016106328A patent/RU2694056C2/ru not_active IP Right Cessation
- 2014-07-22 SG SG11201510732VA patent/SG11201510732VA/en unknown
- 2014-07-22 US US14/906,885 patent/US9814680B2/en not_active Expired - Fee Related
- 2014-07-22 SG SG10201803996WA patent/SG10201803996WA/en unknown
- 2014-07-22 CA CA2918528A patent/CA2918528A1/en not_active Withdrawn
- 2014-07-22 EP EP14741647.3A patent/EP3024444A1/en not_active Withdrawn
- 2014-07-25 TW TW103125582A patent/TWI630911B/zh active
-
2015
- 2015-12-28 IL IL243369A patent/IL243369A0/en unknown
-
2016
- 2016-01-06 ZA ZA2016/00110A patent/ZA201600110B/en unknown
- 2016-01-19 PH PH12016500119A patent/PH12016500119A1/en unknown
- 2016-01-21 SA SA516370446A patent/SA516370446B1/ar unknown
- 2016-01-22 CL CL2016000183A patent/CL2016000183A1/es unknown
- 2016-06-15 HK HK16106876.8A patent/HK1218861A1/zh unknown
-
2018
- 2018-04-04 JP JP2018072182A patent/JP6476331B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| SG11201510732VA (en) | 2016-01-28 |
| AU2014295099A1 (en) | 2016-02-11 |
| JP6476331B2 (ja) | 2019-02-27 |
| AU2014295099B2 (en) | 2019-07-11 |
| PE20160245A1 (es) | 2016-05-10 |
| US20160184231A1 (en) | 2016-06-30 |
| WO2015011162A1 (en) | 2015-01-29 |
| RU2016106328A (ru) | 2017-08-31 |
| EP3024444A1 (en) | 2016-06-01 |
| TWI630911B (zh) | 2018-08-01 |
| TW201601723A (zh) | 2016-01-16 |
| SA516370446B1 (ar) | 2018-09-13 |
| CN105407876A (zh) | 2016-03-16 |
| IL243369A0 (en) | 2016-02-29 |
| SG10201803996WA (en) | 2018-06-28 |
| JP2016539110A (ja) | 2016-12-15 |
| MX2016001155A (es) | 2016-04-29 |
| CA2918528A1 (en) | 2015-01-29 |
| JP2018123147A (ja) | 2018-08-09 |
| US9814680B2 (en) | 2017-11-14 |
| RU2694056C2 (ru) | 2019-07-09 |
| CL2016000183A1 (es) | 2016-07-01 |
| ZA201600110B (en) | 2017-04-26 |
| CN105407876B (zh) | 2019-08-30 |
| PH12016500119A1 (en) | 2016-04-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL245345A0 (en) | History of pyridine, pyrimidine, pyrazine and pyridazine, their preparation and pharmaceutical preparations containing them | |
| EP2815746A4 (en) | SAPONIN NANOMIZELES, MANUFACTURING METHOD, APPLICATION THEREOF AND PHARMACEUTICAL COMPOSITION THEREOF | |
| IL271352B (en) | A pharmaceutical preparation containing a derivative of glutarimide and its use in the treatment of eosinophilic diseases | |
| HK1212980A1 (zh) | 吡啶酮類衍生物、其製備方法及其在醫藥上的應用 | |
| IL240291A0 (en) | History of pyridazinone and pharmaceutical preparations containing them | |
| HK1221649A1 (zh) | 包含乙酰水楊酸和氯吡格雷的藥物片劑 | |
| IL240496B (en) | History of pyridine, process for their preparation, pharmaceutical preparations containing them and their use in medicine | |
| EP2978423A4 (en) | STABLE NANO COMPOSITION WITH DOXORUBICIN, PROCESS FOR THE PREPARATION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH | |
| IL243227A0 (en) | History of diaminocyclopentane carboxamide, their preparation and pharmaceutical preparations containing them | |
| HK1214519A1 (zh) | 雙用途硫酸鹽口服藥物組合物片劑及其使用方法 | |
| PT3102187T (pt) | Composições farmacêuticas estáveis contendo sitagliptina sob a forma de comprimidos de libertação imediata | |
| EP2978428A4 (en) | STABLE NANO COMPOSITION WITH EPIRUBICIN, PROCESS FOR THE PRODUCTION THEREOF, THE USE THEREOF AND PHARMACEUTICAL COMPOSITIONS THEREWITH | |
| HK1218861A1 (zh) | 包含異煙肼顆粒和利福噴汀顆粒的呈可分散的片劑形式的抗結核病的穩定的藥物組合物及其製備方法 | |
| HK1245155A1 (zh) | 製備去氧腎上腺素樹脂酸鹽顆粒的方法；去氧腎上腺素樹脂酸鹽顆粒；以及去氧腎上腺素樹脂酸鹽顆粒在藥物製劑中的用途 | |
| HK1218862A1 (zh) | 包含異煙肼顆粒和利福噴汀顆粒的呈包衣片劑形式的抗結核病的穩定的藥物組合物及其製備方法 | |
| IL245415A0 (en) | A process for the preparation of methylphenidate and its pharmaceutical salts | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| MX2016006742A (es) | Composicion farmaceutica. | |
| HRP20180781T1 (hr) | Farmaceutski pripravak koji sadržava lidipidipin i proces pripreme | |
| ZA201506665B (en) | Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters | |
| ZA201506656B (en) | Pharmaceutical compositions of donepezil having specific in vitro dissolution profile or pharmacokinetics parameters | |
| TH1601000296A (th) | องค์ประกอบทางเภสัชกรรมที่เสถียรซึ่งต้านวัณโรคในรูปของยาเม็ดแบนชนิดที่แตกตัว อย่างรวดเร็วซึ่งประกอบรวมด้วยแกรนูลของไอโซไนอาซิดและแกรนูลของ ไรฟาเพนทีน และกระบวนการเตรียมของมัน |